Financial Gravity Asset Management, Inc. Biomarin Pharmaceutical Inc Transaction History

Financial Gravity Asset Management, Inc.

$400 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 26, 2024	SELL	$83.81 - $99.0 $502 - $594	-6 Reduced 46.15%	7 $654,000
Q1 2024 May 13, 2024	BUY	$83.81 - $99.0 $335 - $396	4 Added 30.77%	17 $1.52 Million
Q4 2023 Jun 26, 2024	SELL	$76.22 - $98.51 $304 - $394	-4 Reduced 23.53%	13 $1.49 Million
Q3 2023 Nov 15, 2023	SELL	$85.07 - $94.48 $6,295 - $6,991	-74 Reduced 85.06%	13 $1,000
Q2 2023 Aug 08, 2023	SELL	$86.68 - $100.3 $866 - $1,003	-10 Reduced 10.31%	87 $1.1 Million
Q1 2023 May 12, 2023	SELL	$87.74 - $117.27 $526 - $703	-6 Reduced 5.83%	97 $1.39 Million
Q4 2022 Feb 15, 2023	SELL	$80.93 - $108.63 $74,212 - $99,613	-917 Reduced 89.9%	103 $1.39 Million
Q3 2022 Nov 03, 2022	BUY	$82.16 - $96.94 $1,971 - $2,326	24 Added 2.41%	1,020 $1.22 Million
Q2 2022 Aug 05, 2022	BUY	$71.48 - $86.85 $5,146 - $6,253	72 Added 7.79%	996 $1.19 Million
Q1 2022 May 13, 2022	SELL	$74.28 - $92.69 $16,341 - $20,391	-220 Reduced 19.23%	924 $1.11 Million
Q4 2021 Feb 11, 2022	BUY	$71.72 - $91.47 $81,043 - $103,361	1,130 Added 8071.43%	1,144 $1.27 Million
Q2 2021 Aug 11, 2021	SELL	$75.51 - $84.79 $604 - $678	-8 Reduced 36.36%	14 $83,000
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $4,932 - $5,985	-66 Reduced 75.0%	22 $1.67 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $6,389 - $7,937	88 New	88 $7,000
Q2 2020 Aug 13, 2020	SELL	$79.55 - $124.22 $45,661 - $71,302	-574 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$71.37 - $96.85 $28,405 - $38,546	-398 Reduced 40.95%	574 $48,000
Q4 2019 Feb 28, 2020	SELL	$64.27 - $86.37 $31,363 - $42,148	-488 Reduced 33.42%	972 $85,000
Q3 2019 Oct 15, 2019	SELL	$67.4 - $85.11 $22,242 - $28,086	-330 Reduced 18.44%	1,460 $98,000
Q2 2019 Jul 26, 2019	SELL	$80.35 - $93.9 $30,291 - $35,400	-377 Reduced 17.4%	1,790 $153,000
Q1 2019 Apr 19, 2019	BUY	$84.2 - $98.62 $7,241 - $8,481	86 Added 4.13%	2,167 $194,000
Q3 2018 Oct 31, 2018	SELL	$93.92 - $105.72 $9,485 - $10,677	-101 Reduced 4.63%	2,081 $195,000
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $14,061 - $18,320	-185 Reduced 7.82%	2,182 $221,000
Q1 2018 May 23, 2018	BUY	$77.67 - $92.63 $183,844 - $219,255	2,367 New	2,367 $195,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.

Account